Hedera Dx
PrivateLast Round
Series A
May 27, 2025
Total Funding Raised
$30.9M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Hedera Dx operates in Healthcare & Life Sciences and is based in Epalinges. Its latest recorded funding round was a Series A round in May 2025.
Hedera Dx is a biotechnology company that develops and provides liquid biopsy solutions and software for hospital laboratories to conduct in-house, blood-based cancer testing.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Healthcare Analytics, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware + Subscription, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Hedera Dx Comparables
Compare Hedera Dx with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| OncoDNA | 77% | |
| Avitia | 76% | |
| Illumina, Inc. | 75% |
For institutional investors. Book with your work email.
Hedera Dx Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | May 27, 2025 | ||||
| Seed | Sep 21, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Hedera Dx Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| ReykVC | Series A |
| Top Harvest Capital | Seed, Series A |
| Tesi | Series A |
| Air Street Capital | Seed |
| Top Harvest Capital | Seed |
| Eyrir Venture Management | Series A |
| Amino Collective | Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 52% MoM, reaching 2.1K.
- Jun 19, 2026
Monthly visitors grew 721% MoM, from 250 to 2.1K.
For institutional investors. Book with your work email.
Hedera Dx Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Hedera Dx's valuation, stock price, and market status.
Is Hedera Dx a public or private company?
Hedera Dx is a private company.
What is the current stock price of Hedera Dx?
Hedera Dx is a private company, so its shares have no public market price. Caplight tracks Hedera Dx's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Hedera Dx worth (valuation)?
Valuation information for Hedera Dx is not publicly available.
Can I buy Hedera Dx stock?
Hedera Dx shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Hedera Dx's last funding round?
Hedera Dx's most recent funding round was Series A on May 27, 2025.
Who are the main investors in Hedera Dx?
Key investors in Hedera Dx include Top Harvest Capital, Vsquared Ventures.
Will Hedera Dx IPO soon?
No public IPO plans have been announced for Hedera Dx.
How can I track Hedera Dx secondary market activity?
Caplight tracks bids, offers, and trades in Hedera Dx's shares on secondary markets.